The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system

J. S. Skyler

doi:10.1089/15209150050214069

The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system

J. S. Skyler

Medicine

Research output: Contribution to journal › Article

21 Scopus citations

Original language	English (US)
Pages (from-to)	S7-S12
Journal	Diabetes Technology and Therapeutics
Volume	2
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1089/15209150050214069
State	Published - Jan 1 2000

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

Access to Document

10.1089/15209150050214069

Cite this

Skyler, J. S. (2000). The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system. Diabetes Technology and Therapeutics, 2(SUPPL. 1), S7-S12. https://doi.org/10.1089/15209150050214069

@article{8365a4f1cddf442ab14a9795b8bd541f,

title = "The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system",

author = "Skyler, {J. S.}",

year = "2000",

month = jan,

day = "1",

doi = "10.1089/15209150050214069",

language = "English (US)",

volume = "2",

pages = "S7--S12",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - The economic burden of diabetes and the benefits of improved glycemic control

T2 - The potential role of a continuous glucose monitoring system

AU - Skyler, J. S.

PY - 2000/1/1

Y1 - 2000/1/1

UR - http://www.scopus.com/inward/record.url?scp=0034493835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034493835&partnerID=8YFLogxK

U2 - 10.1089/15209150050214069

DO - 10.1089/15209150050214069

M3 - Article

C2 - 11469636

AN - SCOPUS:0034493835

VL - 2

SP - S7-S12

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - SUPPL. 1

ER -